PATENT CLAIM ANALYSIS

Application Number: 16012962
Application Type: Utility
Filing Date: 2018-06
Publication Date: 2018-12
Patent Classification: ["424", "648000"]

Abstract:
A formulation and method for treating or preventing a deficiency of certain nutrients in patients undergoing a therapy in which one or more proton pump inhibitors is administered. The formulation includes: a) 1000 mcg of B12, as methylcobalamin; b) 150 mg of Vitamin C; c) 500 mg of calcium citrate; d) 15 mg of elemental iron in a ferrous form.   The formulation may also include 10-50 mg of a proton pump inhibitor.

Claim (Index 10):
A formulation according to  claim 9  wherein said supplement consists essentially of:\n a) 500-1500 mcg of B12, as methylcobalamin; \n b) 100-250 mg of Vitamin C; \n c) 250-1000 mg of calcium citrate; \n d) 10-25 mg of elemental iron in a ferrous form, and \n e) 10-50 mg of a proton pump inhibitor.

Metadata:
- Claim Count in Document: 23.0
- Percentile: 94.0
- Lexical Diversity: 1.47368
- Patent Class: 424.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: False
- Related Applications: ['15083570', '14121768', '14999041', '14194528', '10279708']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7533102124840405
- 35 USC 102 Novelty (BERT): 0.531824256459898
- Combined Prediction Score: 0.7311616168816262
- Mean Citation Score: 288.390652
- Max Citation Score: 357.5249
- Similarity Product: 256.7129986434221

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test